InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Coastlands Capital LP. Director active across 3 companies, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been published. Split: 6 buys · 0 sell. Total volume traded: €36k. Activity tracked since 27 May 2026. The latest transaction was disclosed on 14 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Coastlands Capital LP has 3 filings in total. In the 3 recent sampled filings, the period runs from 2026-05-29 to 2026-07-01, with transactions of type Acquisition. The companies listed are Adial Pharmaceuticals, INC., Pasithea Therapeutics Corp., and Eloxx Pharmaceuticals, Inc., where Coastlands Capital LP is identified as a 10% Owner.